The U.S. Food and Drug Administration (FDA) has authorized the marketing of four electronic nicotine delivery system (ENDS) pods from Glas through the premarket tobacco product application (PMTA) pathway. These products include Classic Menthol, Fresh Menthol, Gold, and Sapphire, each containing 50mg/ml (5%) tobacco-derived nicotine.
This marks the FDA’s first approval of ENDS products that offer non-tobacco and non-menthol flavors. Glas’s devices incorporate advanced technology designed to restrict access and use by youth, including government ID age verification and smartphone Bluetooth pairing. The device does not operate if separated from the paired phone, and random biometric checks ensure the registered adult user is in control.
The FDA’s review found that most adults aged 21 and older completed the age verification process successfully, while the system effectively prevented access by youth and young adults. The applicant demonstrated that the device’s instructions and software were easy for adults to understand and use.
Marketing Restrictions and Monitoring
To further reduce youth exposure, the company must target advertising, marketing, and promotions exclusively to adults aged 21 and older. Glas is required to track and report on the effectiveness of their youth-prevention measures and provide demographic analyses of their audience reach.
The FDA will monitor the products’ marketing and may suspend or withdraw authorization if youth use increases significantly or if the products’ benefits to adult smokers no longer outweigh potential risks.
Current Regulatory Context
The FDA has now authorized 45 ENDS products for market in the United States, which are the only products legally allowed for sale. The agency continues enforcement actions against unauthorized ENDS products and those targeting youth.
While these products may provide less harmful alternatives to combustible cigarettes, the FDA emphasizes that no tobacco product is safe and that youth and non-users should not start using tobacco or nicotine products.
Why it matters
This authorization demonstrates the FDA’s commitment to balancing adult smokers’ access to potentially less harmful alternatives with measures to prevent youth nicotine addiction. The use of technology for age verification in tobacco products introduces a new method for companies to meet public health standards for marketing non-tobacco-flavored ENDS.
Background
Combustible cigarette smoking remains the leading preventable cause of disease and premature death in the U.S., accounting for one in five deaths annually. The FDA has previously authorized multiple ENDS products as part of efforts to provide adult smokers with alternatives and reduce tobacco-related harm.
Sources
This article is based on reporting and publicly available information from the following source:
Read more Health & Public Health stories on Goka World News.